In a profession that increasingly asks us to move faster and do more with less time together, it is worth pausing to remember what cannot be replicated through a screen: the power of showing up in person.
Patient Resources from the Family Heart Foundation
In March 2026, the American College of Cardiology, American Heart Association, and nine other leading medical associations issued updated guidelines for the management of dyslipidemia. The Family Heart Foundation has provided resources to share with patients regarding these new guidelines that explain elevated LDL and Lp(a).
You’ve likely heard of it by now, if not used it most days without realizing it. There are many names for it: AI, Large Language Models, GenAI, ChatGPT, Claude, Grok, DeepSeek. Over the past few years, it has become capable of serving many purposes. There are questions surrounding its use, however, that have not been answered in full.
Are You Required to Participate in Medicare’s New Payment Model? Check the CMS List to Find Out
As previously reported by ACOI, the Centers for Medicare and Medicaid Services (CMS) will launch two new payment models for heart failure and lower back pain on January 1, 2027.
Insurers Make Prior Authorization Data Available to Public
A new federal transparency requirement is making health plan prior authorization data publicly available for the first time—including for many Medicare Advantage (MA), Medicaid managed care, CHIP, and Affordable Care Act Marketplace plans.
U.S. Citizenship and Immigration Services (USCIS) has lifted processing holds on immigration benefit applications filed by or on behalf of medical physicians.
CMS Encourages Providers to Prepare for e-Prior Authorization
Starting January 1, 2027, certain health plans regulated by the Centers for Medicare and Medicaid Services (CMS) must implement and maintain Application Programming Interfaces (APIs) to support electronic prior authorization.
Beginning July 1, 2026 through Dec. 31, 2027, Medicare beneficiaries with Part D coverage may be eligible to access certain GLP-1 medications for $50 per month.
